MiMedx Group, Inc.MDXGNASDAQ
Loading
| Metric | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 |
|---|---|---|---|---|---|
| Revenue Growth | +7.00% | +4.13% | +13.07% | +35.30% | +27.11% |
| Gross Profit Growth | +4.12% | +0.16% | +10.76% | +38.22% | +30.32% |
| EBITDA Growth | -13.23% | -18.14% | -36.88% | +129.28% | +79.79% |
| Operating Income Growth | -28.64% | -37.48% | -47.25% | +98.80% | +90.66% |
| Net Income Growth | -86.09% | -24.17% | -45.43% | +106.89% | +104.21% |
| EPS Growth | -88.23% | -21.01% | -45.75% | +99.64% | +97.63% |
| EPS Diluted Growth | -85.77% | -18.96% | -46.33% | +101.47% | +100.80% |
| Weighted Average Shares Growth | +23.13% | +0.59% | +0.30% | +0.73% | +0.55% |
| Weighted Average Shares Diluted Growth | +0.66% | -0.23% | +0.28% | +0.90% | +0.45% |
| Dividends per Share Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Operating Cash Flow Growth | +83.11% | -11.36% | -33.90% | +49.45% | +32.87% |
| Free Cash Flow Growth | +91.07% | +0.00% | -32.61% | +76.45% | +30.86% |
| Receivables Growth | +3.63% | +9.25% | +31.12% | +44.71% | +35.61% |
| Inventory Growth | +13.25% | -1.57% | -0.66% | +9.29% | +6.44% |
| Asset Growth | +10.40% | +21.99% | +26.47% | +30.79% | +29.83% |
| Book Value per Share Growth | +9.89% | +29.44% | +28.53% | +31.05% | +32.12% |
| Debt Growth | -48.35% | -4.09% | -4.09% | -4.23% | -9.30% |
| R&D Expense Growth | +46.77% | +17.14% | +9.66% | +26.90% | +33.38% |
| SG&A Expenses Growth | +11.32% | +8.17% | +40.37% | +27.39% | +19.62% |